October 15th, 12:00 pm - 1:00 pm Perinatal Mental Health Conditions Bundle Webinar Series « All Events Quick Details Date October 15th 2024, 12:00 pm - 1:00 pm Location In-Person Zoom Speaker Guidelines for Inclusive Content & Delivery https://pnqinma.org/wp-content/uploads/2026/06/V1_PNQIN-Speaker-Guidelines-for-Inclusive-Content-Delivery.pdf PNQIN Speaker Guidelines for Inclusive Content & DeliveryV1, March 2026 These guidelines support inclusive speaker recruitment, educational content, and representation that reflect the diversity of PNQIN’s membership. Our... Communication Association of Prenatal Fentanyl Exposure With Neonatal Opioid Withdrawal Syndrome Severity Abstract OBJECTIVE: Opioid use disorder (OUD) in pregnancy has increased substantially, with illicitfentanyl now the most common illicit opioid. Limited data exist on the impact of antenatalfentanyl exposure on... Neonatal Abstinence Syndrome Opioid and Substance Use Disorders There is no excerpt because this is a protected post. Updated Guidance from ACOG: Zuranolone and Brexanolone for Treatment of Postpartum Depression Co-authored by our MA PMHC Bundle Lead, Dr. Tiffany Moore Simas, this Clinical Practice Update provides revised guidance on the use of both Zuranolone and Brexanolone for management of...
